菌体对抗眼球甲素耐药性S. aureus隔离物在美国收集的体外活性
Camille André1,2, Mathieu Medina2,3, Camille Kolenda2,3
1Departments of Ophthalmology, Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
Ophthalmology and therapy
|March 12, 2025
概括
菌体显示出治疗抗生素耐药MRSA引起的眼部感染的希望. 在实验室测试中,三种特定的菌体 (V1SA19,V1SA20,V1SA22) 对眼部MRSA分离物非常有效.
科学领域:
- 眼科医生 眼科 眼科
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 耐甲基西林黄金葡萄球菌 (MRSA) 在美国引起视力威胁的眼部感染.
- MRSA 菌株通常抵抗眼睛感染的标准抗生素治疗.
- 细菌被探索为难以治疗的眼部感染的新型局部疗法.
研究的目的:
- 评估抗S. aureus菌体对眼部MRSA分离物的体外抗菌活性.
- 为了识别在眼睛感染中发现的针对多药耐药 (MDR) MRSA菌株有效的特定菌体.
主要方法:
- 用点和液体培养试验对50个MDR眼部MRSA分离物进行了六种细菌菌体的测试.
- 宿主范围和有效性在各种菌与细菌的比率 (感染的多重性) 中进行了评估.
主要成果:
- 90%的MRSA分离物对至少一种测试的菌体敏感.
- 菌体V1SA19,V1SA20和V1SA22对分别86%,84%和82%的分离物表现出广泛的活性.
- 在液体培养试验中观察到菌体的剂量依赖作用.
结论:
- 菌体V1SA19,V1SA20和V1SA22对眼部MRSA有显著的抗菌活性.
- 菌体为强硬的MRSA眼部感染的局部治疗提供了一个潜在的新策略.
更多相关视频
12:27Quantifying the Cytotoxicity of Staphylococcus aureus Against Human Polymorphonuclear Leukocytes
Published on: January 3, 2020
6.2K
06:36Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
2.7K
相关概念视频
Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
